Primary Recipient

SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE

Amount

$573,000.00

Award Date

1/11/2010

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

The emerging obesity pandemic is driving an alarming increase in the prevalence of insulin resistant forms of diabetes. The mechanisms whereby obesity leads to insulin resistance remain to be fully elucidated. Chronic caloric excess leads to increased del

Vendors Connected to Award

Vendor	Role	Amount
Integrated DNA Technologies Inc	Primary vendor	$13.68
Qiagen	Primary vendor	$3,672.70
Sigma Aldrich	Primary vendor	$617.40
VWR International	Primary vendor	$1,178.45
A-M Systems LLC	Primary vendor	$185.89
Invitrogen Corp	Primary vendor	$1,103.70
Fisher Scientific	Primary vendor	$1,138.36
FedEx	Primary vendor	$15.67
R&D Systems Inc	Primary vendor	$1,352.77
Perkin Elmer	Primary vendor	$556.80
Grass Technologies	Primary vendor	$2,249.99
American Radiolabeled Chemicals Inc.	Primary vendor	$3,851.00
Applied Biosystems	Primary vendor	$206.75
Waters Technologies Corp	Primary vendor	$1,343.17
Chembridge Corporation	Primary vendor	$190.00
LC Laboratories	Primary vendor	$64.00
Enamine LLC	Primary vendor	$1,102.43
Biotage LLC	Primary vendor	$2,007.79
ChemDiv Inc	Primary vendor	$564.34
EMD Chemicals	Primary vendor	$337.00